Adherence in multiple sclerosis (ADAMS): Classification, relevance, and research needs. A meeting report

C. Heesen, J. Bruce, P. Feys, J. Sastre-Garriga, A. Solari, L. Eliasson, V. Matthews, B. Hausmann, A. Perrin Ross, M Asano, K. Imonen-Charalambous, S. Köpke, Wendy Clyne

    Research output: Contribution to journalArticle

    13 Citations (Scopus)

    Abstract

    Background: Adherence to medical interventions is a global problem. With an increasing amount of partially effective but expensive drug treatments adherence is increasingly relevant in multiple sclerosis (MS). Perceived lack of efficacy and side effects as well as neuropsychiatric factors such as forgetfulness, fatigue and depression are major determinants. However, research on adherence to behavioural interventions as part of rehabilitative interventions has only rarely been studied. Methods: In a one-day meeting health researchers as well as patient representatives and other stakeholders discussed adherence issues in MS and developed a general draft research agenda within a focus group session. Results: The focus group addressed four major areas: (1) focussing patients and their informal team; (2) studying health care professionals; (3) comparing practice across cultures; and (4) studying new adherence interventions. Conclusions: A focus on patient preferences as well as a non-judgemental discussion on adherence issues with patients should be at the core of adherence work.
    Original languageEnglish
    Pages (from-to)1795-1798
    JournalMultiple Sclerosis Journal
    Volume20
    Issue number13
    Early online date22 Apr 2014
    DOIs
    Publication statusPublished - 1 Nov 2014

    Fingerprint

    Focus Groups
    Multiple Sclerosis
    Patient Advocacy
    Patient Preference
    Research
    Fatigue
    Research Personnel
    Delivery of Health Care
    Health
    Pharmaceutical Preparations
    Therapeutics

    Bibliographical note

    There is no full text available on the repository at this time.

    Keywords

    • Disease-modifying therapies
    • multiple sclerosis
    • rehabilitation
    • adherence

    Cite this

    Heesen, C., Bruce, J., Feys, P., Sastre-Garriga, J., Solari, A., Eliasson, L., ... Clyne, W. (2014). Adherence in multiple sclerosis (ADAMS): Classification, relevance, and research needs. A meeting report. Multiple Sclerosis Journal, 20(13), 1795-1798. https://doi.org/10.1177/1352458514531348

    Adherence in multiple sclerosis (ADAMS): Classification, relevance, and research needs. A meeting report. / Heesen, C.; Bruce, J.; Feys, P.; Sastre-Garriga, J.; Solari, A.; Eliasson, L.; Matthews, V.; Hausmann, B.; Perrin Ross, A.; Asano, M; Imonen-Charalambous, K.; Köpke, S.; Clyne, Wendy.

    In: Multiple Sclerosis Journal, Vol. 20, No. 13, 01.11.2014, p. 1795-1798.

    Research output: Contribution to journalArticle

    Heesen, C, Bruce, J, Feys, P, Sastre-Garriga, J, Solari, A, Eliasson, L, Matthews, V, Hausmann, B, Perrin Ross, A, Asano, M, Imonen-Charalambous, K, Köpke, S & Clyne, W 2014, 'Adherence in multiple sclerosis (ADAMS): Classification, relevance, and research needs. A meeting report' Multiple Sclerosis Journal, vol. 20, no. 13, pp. 1795-1798. https://doi.org/10.1177/1352458514531348
    Heesen, C. ; Bruce, J. ; Feys, P. ; Sastre-Garriga, J. ; Solari, A. ; Eliasson, L. ; Matthews, V. ; Hausmann, B. ; Perrin Ross, A. ; Asano, M ; Imonen-Charalambous, K. ; Köpke, S. ; Clyne, Wendy. / Adherence in multiple sclerosis (ADAMS): Classification, relevance, and research needs. A meeting report. In: Multiple Sclerosis Journal. 2014 ; Vol. 20, No. 13. pp. 1795-1798.
    @article{0fba5552eff74b6484c505cd26f1b4ba,
    title = "Adherence in multiple sclerosis (ADAMS): Classification, relevance, and research needs. A meeting report",
    abstract = "Background: Adherence to medical interventions is a global problem. With an increasing amount of partially effective but expensive drug treatments adherence is increasingly relevant in multiple sclerosis (MS). Perceived lack of efficacy and side effects as well as neuropsychiatric factors such as forgetfulness, fatigue and depression are major determinants. However, research on adherence to behavioural interventions as part of rehabilitative interventions has only rarely been studied. Methods: In a one-day meeting health researchers as well as patient representatives and other stakeholders discussed adherence issues in MS and developed a general draft research agenda within a focus group session. Results: The focus group addressed four major areas: (1) focussing patients and their informal team; (2) studying health care professionals; (3) comparing practice across cultures; and (4) studying new adherence interventions. Conclusions: A focus on patient preferences as well as a non-judgemental discussion on adherence issues with patients should be at the core of adherence work.",
    keywords = "Disease-modifying therapies, multiple sclerosis, rehabilitation, adherence",
    author = "C. Heesen and J. Bruce and P. Feys and J. Sastre-Garriga and A. Solari and L. Eliasson and V. Matthews and B. Hausmann and {Perrin Ross}, A. and M Asano and K. Imonen-Charalambous and S. K{\"o}pke and Wendy Clyne",
    note = "There is no full text available on the repository at this time.",
    year = "2014",
    month = "11",
    day = "1",
    doi = "10.1177/1352458514531348",
    language = "English",
    volume = "20",
    pages = "1795--1798",
    journal = "Multiple Sclerosis",
    issn = "1352-4585",
    publisher = "SAGE Publications",
    number = "13",

    }

    TY - JOUR

    T1 - Adherence in multiple sclerosis (ADAMS): Classification, relevance, and research needs. A meeting report

    AU - Heesen, C.

    AU - Bruce, J.

    AU - Feys, P.

    AU - Sastre-Garriga, J.

    AU - Solari, A.

    AU - Eliasson, L.

    AU - Matthews, V.

    AU - Hausmann, B.

    AU - Perrin Ross, A.

    AU - Asano, M

    AU - Imonen-Charalambous, K.

    AU - Köpke, S.

    AU - Clyne, Wendy

    N1 - There is no full text available on the repository at this time.

    PY - 2014/11/1

    Y1 - 2014/11/1

    N2 - Background: Adherence to medical interventions is a global problem. With an increasing amount of partially effective but expensive drug treatments adherence is increasingly relevant in multiple sclerosis (MS). Perceived lack of efficacy and side effects as well as neuropsychiatric factors such as forgetfulness, fatigue and depression are major determinants. However, research on adherence to behavioural interventions as part of rehabilitative interventions has only rarely been studied. Methods: In a one-day meeting health researchers as well as patient representatives and other stakeholders discussed adherence issues in MS and developed a general draft research agenda within a focus group session. Results: The focus group addressed four major areas: (1) focussing patients and their informal team; (2) studying health care professionals; (3) comparing practice across cultures; and (4) studying new adherence interventions. Conclusions: A focus on patient preferences as well as a non-judgemental discussion on adherence issues with patients should be at the core of adherence work.

    AB - Background: Adherence to medical interventions is a global problem. With an increasing amount of partially effective but expensive drug treatments adherence is increasingly relevant in multiple sclerosis (MS). Perceived lack of efficacy and side effects as well as neuropsychiatric factors such as forgetfulness, fatigue and depression are major determinants. However, research on adherence to behavioural interventions as part of rehabilitative interventions has only rarely been studied. Methods: In a one-day meeting health researchers as well as patient representatives and other stakeholders discussed adherence issues in MS and developed a general draft research agenda within a focus group session. Results: The focus group addressed four major areas: (1) focussing patients and their informal team; (2) studying health care professionals; (3) comparing practice across cultures; and (4) studying new adherence interventions. Conclusions: A focus on patient preferences as well as a non-judgemental discussion on adherence issues with patients should be at the core of adherence work.

    KW - Disease-modifying therapies

    KW - multiple sclerosis

    KW - rehabilitation

    KW - adherence

    U2 - 10.1177/1352458514531348

    DO - 10.1177/1352458514531348

    M3 - Article

    VL - 20

    SP - 1795

    EP - 1798

    JO - Multiple Sclerosis

    JF - Multiple Sclerosis

    SN - 1352-4585

    IS - 13

    ER -